Bessemer Group Inc. Has $241.79 Million Stock Position in CME Group Inc. (NASDAQ:CME)

Bessemer Group Inc. reduced its holdings in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 1.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 911,408 shares of the financial services provider's stock after selling 11,397 shares during the period. Bessemer Group Inc. owned about 0.25% of CME Group worth $241,788,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in CME. waypoint wealth counsel purchased a new position in CME Group in the first quarter valued at $228,000. Adams Diversified Equity Fund Inc. acquired a new position in shares of CME Group during the 1st quarter worth about $23,107,000. Golden State Equity Partners lifted its stake in CME Group by 2.0% during the first quarter. Golden State Equity Partners now owns 3,538 shares of the financial services provider's stock worth $939,000 after purchasing an additional 70 shares during the last quarter. Global Assets Advisory LLC purchased a new stake in CME Group during the first quarter worth approximately $726,000. Finally, Moran Wealth Management LLC boosted its holdings in CME Group by 16.2% in the first quarter. Moran Wealth Management LLC now owns 83,296 shares of the financial services provider's stock valued at $22,098,000 after purchasing an additional 11,643 shares in the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.

CME Group Stock Performance

Shares of NASDAQ CME traded down $0.20 during mid-day trading on Thursday, hitting $272.83. The company had a trading volume of 2,428,655 shares, compared to its average volume of 2,226,260. CME Group Inc. has a 12 month low of $193.17 and a 12 month high of $290.79. The firm has a market cap of $98.32 billion, a P/E ratio of 25.85, a PEG ratio of 3.70 and a beta of 0.45. The business's 50-day simple moving average is $274.76 and its 200-day simple moving average is $256.04. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, beating the consensus estimate of $2.61 by $0.19. CME Group had a return on equity of 14.03% and a net margin of 57.71%. The company had revenue of $1.64 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same period in the prior year, the company posted $2.50 EPS. The company's revenue was up 10.4% compared to the same quarter last year. As a group, analysts predict that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th were paid a dividend of $1.25 per share. The ex-dividend date was Monday, June 9th. This represents a $5.00 annualized dividend and a yield of 1.83%. CME Group's dividend payout ratio is 50.30%.

Insider Transactions at CME Group

In related news, Director William R. Shepard acquired 256 shares of the company's stock in a transaction that occurred on Wednesday, June 25th. The stock was acquired at an average price of $270.53 per share, for a total transaction of $69,255.68. Following the completion of the acquisition, the director now owns 258,196 shares of the company's stock, valued at $69,849,763.88. This trade represents a 0.10% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider Derek Sammann sold 4,650 shares of the firm's stock in a transaction dated Monday, May 5th. The stock was sold at an average price of $280.61, for a total value of $1,304,836.50. Following the transaction, the insider now owns 8,336 shares in the company, valued at approximately $2,339,164.96. This trade represents a 35.81% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 13,400 shares of company stock valued at $3,680,610. Corporate insiders own 0.30% of the company's stock.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on CME. Morgan Stanley increased their price objective on CME Group from $301.00 to $304.00 and gave the company an "overweight" rating in a report on Thursday, April 24th. UBS Group upped their target price on shares of CME Group from $290.00 to $305.00 and gave the stock a "buy" rating in a research report on Friday, April 25th. JPMorgan Chase & Co. dropped their target price on shares of CME Group from $223.00 to $211.00 and set an "underweight" rating for the company in a report on Thursday, April 24th. Erste Group Bank cut CME Group from a "strong-buy" rating to a "hold" rating in a report on Saturday, May 24th. Finally, Piper Sandler boosted their price target on CME Group from $275.00 to $283.00 and gave the stock an "overweight" rating in a report on Tuesday, April 8th. Three investment analysts have rated the stock with a sell rating, eight have issued a hold rating and five have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $258.20.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.